Similarly, the nucleophosmin–anaplastic lymphoma kinase (NPM-ALK) is a fusion protein kinase which is generated in 30–50% of patients with advanced-stage anaplastic large-cell lymphoma. The gene discussed is NPM1; the disease is anaplastic large cell lymphoma.